
|Articles|October 19, 2019
Spray drying for enhancing the solubility of poorly soluble drugs
Spray drying continues to gain importance as a preferred manufacturing technology for amorphous solid dispersions (ASD). A fast carrier selection allows for a more targeted development process with reduced time to market. EUDRAGIT® polymers have not only been proven to be superior with respect to ASD formations but can also stabilize the amorphous state of the API over storage.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
UK’s Persistent Failure to Commercialize R&D Threatens Life Sciences: Report
2
PharmTech Weekly News Roundup — Week of November 10, 2025
3
At AAPS PharmSci 360, Solutions for Challenges in Amorphous Solid Dispersion Development
4
Achieving a Personalized Digital Control Arm for Preclinical Drug Evaluation
5
